NO20023607D0 - Kontraseptivpreparat for hannkjönn omfattende noretisterone - Google Patents

Kontraseptivpreparat for hannkjönn omfattende noretisterone

Info

Publication number
NO20023607D0
NO20023607D0 NO20023607A NO20023607A NO20023607D0 NO 20023607 D0 NO20023607 D0 NO 20023607D0 NO 20023607 A NO20023607 A NO 20023607A NO 20023607 A NO20023607 A NO 20023607A NO 20023607 D0 NO20023607 D0 NO 20023607D0
Authority
NO
Norway
Prior art keywords
norethisterone
male
testosterone
males
progestin
Prior art date
Application number
NO20023607A
Other languages
English (en)
Other versions
NO20023607L (no
Inventor
Eberhard Nieschlag
Axel Kamischke
Michael Oettel
Alexander Ruebig
Ekkerhard Schillinger
Ursula-Friederike Habenicht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20023607D0 publication Critical patent/NO20023607D0/no
Publication of NO20023607L publication Critical patent/NO20023607L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20023607A 2000-02-15 2002-07-30 Kontraseptivpreparat for hannkjönn omfattende noretisterone NO20023607L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
EP00200493 2000-02-15
PCT/IB2001/000188 WO2001060376A1 (en) 2000-02-15 2001-02-15 Male contraceptive formulation comprising norethisterone

Publications (2)

Publication Number Publication Date
NO20023607D0 true NO20023607D0 (no) 2002-07-30
NO20023607L NO20023607L (no) 2002-10-15

Family

ID=26071832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023607A NO20023607L (no) 2000-02-15 2002-07-30 Kontraseptivpreparat for hannkjönn omfattende noretisterone

Country Status (26)

Country Link
EP (2) EP1267885B8 (no)
JP (1) JP2003522795A (no)
KR (1) KR20020086905A (no)
CN (1) CN1423560A (no)
AT (2) ATE355844T1 (no)
AU (1) AU2001230447A1 (no)
BG (1) BG107066A (no)
BR (1) BR0108411A (no)
CA (1) CA2398063A1 (no)
CY (1) CY1106639T1 (no)
CZ (1) CZ20022691A3 (no)
DE (2) DE60142647D1 (no)
DK (1) DK1267885T3 (no)
EE (1) EE200200454A (no)
ES (1) ES2282230T3 (no)
HK (1) HK1049442B (no)
HU (1) HUP0300128A3 (no)
IL (1) IL151219A0 (no)
MX (1) MXPA02007675A (no)
NO (1) NO20023607L (no)
PL (1) PL357185A1 (no)
PT (1) PT1267885E (no)
RU (1) RU2002124602A (no)
SI (1) SI1267885T1 (no)
SK (1) SK11602002A3 (no)
WO (1) WO2001060376A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
EP1523568A2 (de) 2002-07-24 2005-04-20 Schering Aktiengesellschaft Mikrobiologische verfahren zur herstellung von 7alpha-substituierten 11alpha-hydroxysteroiden
WO2004011008A1 (de) * 2002-07-25 2004-02-05 Schering Aktiengesellschaft ZUSAMMENSETZUNG, ENTHALTEND EIN ANDROGENES 11β-HALOGENSTEROID UND EIN GESTAGEN SOWIE MÄNNLICHES KONTRAZEPTIVUM AUF BASIS DIESER ZUSAMMENSETZUNG
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
PT3562485T (pt) 2018-03-23 2020-08-27 Laboratoires Major Composições e métodos não hormonais para contraceção masculina compreendendo (r)-silodosina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Also Published As

Publication number Publication date
SK11602002A3 (sk) 2003-03-04
EP1666044B1 (en) 2010-07-21
PL357185A1 (en) 2004-07-26
ES2282230T3 (es) 2007-10-16
AU2001230447A1 (en) 2001-08-27
ATE355844T1 (de) 2007-03-15
BR0108411A (pt) 2003-03-11
DE60127103D1 (de) 2007-04-19
CN1423560A (zh) 2003-06-11
CA2398063A1 (en) 2001-08-23
WO2001060376A1 (en) 2001-08-23
PT1267885E (pt) 2007-05-31
NO20023607L (no) 2002-10-15
ATE474580T1 (de) 2010-08-15
HK1049442B (zh) 2007-06-15
SI1267885T1 (sl) 2007-08-31
DK1267885T3 (da) 2007-07-09
EP1666044A1 (en) 2006-06-07
KR20020086905A (ko) 2002-11-20
CZ20022691A3 (cs) 2003-01-15
EP1267885A1 (en) 2003-01-02
CY1106639T1 (el) 2012-01-25
EP1267885B8 (en) 2007-06-20
RU2002124602A (ru) 2004-03-10
EP1267885B1 (en) 2007-03-07
BG107066A (en) 2003-05-30
HK1049442A1 (en) 2003-05-16
EE200200454A (et) 2003-12-15
IL151219A0 (en) 2003-04-10
DE60127103T2 (de) 2007-11-22
HUP0300128A3 (en) 2004-03-29
JP2003522795A (ja) 2003-07-29
DE60142647D1 (de) 2010-09-02
MXPA02007675A (es) 2004-02-26
HUP0300128A2 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
CY1106639T1 (el) Τυποποιηση αντισυλληπτικου για ανδρες που περιλαμβανει νορεθιστερονη
NO20032805D0 (no) Preparater av östrogensyklodekstrinkomplekser
GEP20053586B (en) Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
AU9041991A (en) Transdermal contraceptive formulations, methods and devices
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
DE59510887D1 (de) Feste arzneiformen, enthaltend clathrate vom steroidalen sexualhormon ethinylestradiol
CY1106086T1 (el) Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα
CA2467237A1 (en) Method of preventing or treating benign gynaecological disorders
DE59805902D1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
IL148116A0 (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
AR027526A1 (es) Formulacion anticonceptiva masculina que comprende noretisterona
PE20010579A1 (es) Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos
EP1513588B1 (en) Use of new etonogestrel esters
JP2003522795A5 (no)
WO1999045886A3 (en) New contraceptive kit for monotherapy
HUP0301592A2 (hu) 16alfa-metil- vagy etil-szubsztituált ösztrogének és ezeket tartalmazó gyógyszerkészítmények
PE20020709A1 (es) Composiciones de complejos de estrogeno-ciclodextrina
CU22840A1 (es) Derivados esteroidales de la serie del androstano sustituídos en el anillo c que presentan marcada actividad anabólica e insignificante actividad androgénica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application